Cellular biology of prion diseases

Clinical Microbiology Reviews

Volumn 12, Issue 3, 1999, Pages 429-444

  Harris, David A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ARTICLE; CONFORMATIONAL TRANSITION; HUMAN; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRION DISEASE; PROTEIN CONFORMATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION;

ANIMALIA;

EID: 0032802332     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.12.3.429     Document Type: Article

References (187)

1. Alper, T., W. A. Cramp, D. A. Haig, and M. C. Clarke. 1967. Does the agent of scrapie replicate without nucleic acid? Nature 214:764-766.
2. Anderson, R. G. W. 1993. Plasmalemmal caveolae and GPI-anchored membrane proteins. Curr. Opin. Cell Biol. 5:647-652.
3. Anderson, R. M., C. A. Donnelly, N. M. Ferguson, M. E. J. Woolhouse, C. J. Watt, H. J. Udy, S. MaWhinney, S. P. Dunstan, M. E. J. Southwood, J. W. Wilesmith, J. B. M. Ryan, L. J. Hoinville, J. E. Hillerton, A. R. Austin, and G. A. H. Wells. 1996. Transmission dynamics and epidemiology of BSE in British cattle. Nature 382:779-788.
4. Arnold, J. E., C. Tipler, L. Laszlo, J. Hope, M. Landon, and R. J. Mayer. 1995. The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain. J. Pathol. 176: 403-411.
5. Bamborough, P., H. Wille, G. C. Telling, F. Yehiely, S. B. Prusiner, and F. E. Cohen. 1996. Prion protein structure and scrapie replication: theoretical, spectroscopic, and genetic investigations. Cold Spring Harbor Symp. Quant. Biol. 61:495-509.
6. Bendheim, P. E., H. R. Brown, R. D. Rudelli, L. J. Scala, N. L. Goller, G. Y. Wen, R. J. Kascsak, N. R. Cashman, and D. C. Bolton. 1992. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42:149-156.
7. Hessen, R. A., D. A. Kocisko, G. J. Raymond, S. Nandan, P. T. Lansbury, and B. Caughey. 1995. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375:698-700.
8. Bessen, R. A., and R. F. Marsh. 1992. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 66:2096-2101.
9. Blättler, T., S. Brandner, A. J. Raeber, M. A. Klein, T. Volgtländer, C. Weissmann, and A. Aguzzi. 1997. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389:69-73.
10. Bolton, D. C., and P. E. Bendheim. 1988. A modified host protein model of scrapie, p. 164-181. In F. Brown (ed.), Ciba Foundation Symposium, vol. 135. Novel infectious agents and the central nervous system. John Wiley & Sons, Chichester, United Kingdom.
11. Borchelt, D. R., V. E. Koliatsos, M. Guarnieri, C. A. Pardo, S. S. Sisodia, and D. L. Price. 1994. Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems. J. Biol. Chem. 269:14711-14714.
12. Borchelt, D. R., M. Rogers, N. Stahl, G. Telling, and S. B. Prusiner. 1993. Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology 3:319-329.
13. Borchelt, D. R., M. Scott, A. Taraboulos, N. Stahl, and S. B. Prusiner. 1990. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J. Cell Biol. 110:743-752.
14. Borchelt, D. R., A. Taraboulos, and S. B. Prusiner. 1992. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267:16188-16199.
15. 14a.Brewer, J. A., and D. A. Harris. Unpublished data.
16. Brown, D. R., K. F. Qin, J. W. Herms, A. Madlung, J. Manson, R. Strome, P. E. Fraser, T. Kruck, A. Vonbohlen, W. Schulzschaeffer, A. Giese, D. Westaway, and H. Kretzschmar. 1997. The cellular prion protein binds copper in vivo. Nature 390:684-687.
17. Brown, D. R., W. J. Schulzschaeffer, B. Schmidt, and H. A. Kretzschmar. 1997. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146:104-112.
18. Brown, P. 1998. Donor pool size and the risk of blood-borne Creutzfeldt-Jakob disease. Transfusion 38:312-315.
19. Brown, P., M. A. Preece, and R. G. Will. 1992. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 340:24-27.
20. Bruce, M. E., R. G. Will, J. W. Ironside, I. McConnell, D. Drummond, A. Suttie, L. McCardle, A. Chree, J. Hope, C. Birkett, S. Cousens, H. Fraser, and C. J. Bostock. 1997. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389:498-501.
21. Büeler, H., A. Aguzzi, A. Sailer, R. A. Greiner, P. Autenried, M. Aguet, and C. Weissmann. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347.
22. Büeler, H., M. Fischer, Y. Lang, H. Fluethmann, H.-P. Lipp, S. J. DeArmond, S. B. Prusiner, M. Aguet, and C. Weissmann. 1992. Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582.
23. Butler, D. A., M. R. D. Scott, J. M. Bockman, D. R. Borchelt, A. Taraboulos, K. K. Hsiao, D. T. Kingsbury, and S. B. Prusiner. 1988. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J. Virol. 62:1558-1564.
24. Caughey, B., and B. Chesebro. 1997. Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol. 7:56-62.
25. Caughey, B., K. Neary, R. Buller, D. Ernst, L. L. Perry, B. Chesebro, and R. E. Race. 1990. Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells. J. Virol. 64:1093-1101.
26. Caughey, B., R. E. Race, and B. Chesebro. 1988. Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines. J. Gen. Virol. 69:711-716.
27. Caughey, B., R. E. Race, D. Ernst, M. J. Buchmeier, and B. Chesebro. 1989. Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J. Virol. 63:175-181.
28. Caughey, B., R. E. Race, M. Vogel, M. J. Buchmeier, and B. Chesebro. 1988. In vitro expression in eukaryotic cells of a prion protein gene cloned from scrapie-infected mouse brain. Proc. Natl. Acad. Sci. USA 85:4657-4661.
29. Caughey, B., and G. J. Raymond. 1991. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease-and phospholipase-sensitive. J. Biol. Chem. 266:18217-18223.
30. Caughey, B., G. J. Raymond, D. Ernst, and R. E. Race. 1991. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 65:6597-6603.
31. Caughey, B., G. J. Raymond, D. A. Kocisko, and P. T. Lansbury. 1997. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. J. Virol. 71:4107-4110.
32. Caughey, B. W., A. Dong, K. S. Bhat, D. Ernst, S. F. Hayes, and W. S. Caughey. 1991. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30:7672-7680.
33. Chang, W.-J., Y.-S. Ying, K. G. Rothberg, N. M. Hooper, A. J. Turner, H. A. Gambliel, J. De Gunzburg, S. M. Mumby, A. G. Gilman, and R. G. W. Anderson. 1994. Purification and characterization of smooth muscle caveolae. J. Cell Biol. 126:127-138.
34. Chazot, G., E. Broussolle, C. Lapras, T. Blattler, A. Aguzzi, and N. Kopp. 1996. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347:1181.
35. Chen, S. G., D. B. Teplow, P. Parchi, J. K. Teller, P. Gambetti, and L. Autilio-Gambetti. 1995. Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270:19173-19180.
36. +]. Science 268:880-884.
37. Chesebro, B. 1998. BSE and prions: uncertainties about the agent. Science 279:42-43.
38. Chiesa, R., and D. A. Harris. Unpublished data.
39. Chiesa, R., P. Piccardo, B. Ghetti, and D. A. Harris. 1998. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21:1339-1351.
40. Cohen, F. E., K. M. Pan, Z. Huang, M. Baldwin, R. J. Fletterick, and S. B. Prusiner. 1994. Structural clues to prion replication. Science 264:530-531.
41. 2+-activated K+ currents. Neurosci. Lett. 209:49-52.
42. Colling, S. B., M. Khana, J. Collinge, and J. G. R. Jefferys. 1997. Mossy fibre reorganization in the hippocampus of prion protein null mice. Brain Res. 755:28-35.
43. Collinge, J., K. C. L. Sidle, J. Meads, J. Ironside, and A. F. Hill. 1996. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383:685-690.
44. Collinge, J., M. A. Whittington, K. C. Sidle, C. J. Smith, M. S. Palmer, A. R. Clarke, and J. G. Jefferys. 1994. Prion protein is necessary for normal synaptic function. Nature 370:295-297.
45. Come, J. H., P. E. Fraser, and P. T. Lansbury. 1993. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl. Acad. Sci. USA 90:5959-5963.
46. Coustou, V., C. Deleu, S. Saupe, and J. Begueret. 1997. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl. Acad. Sci. USA 94:9773-9778.
47. Cuillé, J., and P. L. Chelle. 1939. Experimental transmission of trembling to the goat. CR Seances Acad. Sci. 208:1058-1060.
48. Daude, N., S. Lehmann, and D. A. Harris. 1997. Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells. J. Biol. Chem. 272:11604-11612.
49. DeArmond, S. J., M. P. McKinley, R. A. Barry, M. B. Braunfeld, J. R. McColloch, and S. B. Prusiner. 1985. Identification of prion amyloid filaments in scrapie-infected brain. Cell 41:221-235.
50. DeArmond, S. J., W. C. Mobley, D. L. DeMott, R. A. Barry, J. H. Beckstead, and S. B. Prusiner. 1987. Changes in the localization of brain prion proteins during scrapie infection. Neurology 37:1271-1280.
51. DeArmond, S. J., H. Sanchez, F. Yehiely, Y. Qiu, A. Ninchakcasey, V. Daggett, A. P. Camerino, J. Cayetano, M. Rogers, D. Groth, M. Torchia, P. Tremblay, M. R. Scott, F. E. Cohen, and S. B. Prusiner. 1997. Selective neuronal targeting in prion disease. Neuron 19:1337-1348.
52. DebBurman, S. K., G. J. Raymond, B. Caughey, and S. Lindquist. 1997. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc. Natl. Acad. Sci. USA 94:13938-13943.
53. De Fea, K. A., D. H. Nakahara, M. C. Calayag, C. S. Yost, L. F. Mirels, S. B. Prusiner, and V. R. Lingappa. 1994. Determinants of carboxyl-terminal domain translocation during prion protein biogenesis. J. Biol. Chem. 269: 16810-16820.
54. Diedrich, J. F., P. E. Bendheim, Y. S. Kim, R. I. Carp, and A. T. Haase. 1991. Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc. Natl. Acad. Sci. USA 88:375-379.
55. Dodelet, V. C., and N. R. Cashman. 1998. Prion protein expression in human leukocyte differentiation. Blood 91:1556-1561.
56. Donne, D. G., J. H. Viles, D. Groth, I. Mehlhorn, T. L. James, F. E. Cohen, S. B. Prusiner, P. E. Wright, and H. J. Dyson. 1997. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl. Acad. Sci. USA 94:13452-13457.
57. C interacts with molecular chaperones of the Hsp60 family. J. Virol. 70:4724-4728.
58. Endo, T., D. Groth, S. B. Prusiner, and A. Kobata. 1989. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28:8380-8388.
59. Fischer. M., T. Rülicke, A. Raeber, A. Sailer, M. Moser, B. Oesch, S. Brandner, A. Aguzzi, and C. Weissmann. 1996. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15:1255-1264.
60. C) in synaptic boutons of normal hamster hippocampus. C. R. Acad. Sci. Paris 318: 339-344.
61. Gajdusek, D. C. 1994. Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses. Mol. Neurobiol. 8:1-13.
62. Gajdusek, D. C. 1996. Infectious amyloids: subacute spongiform encephalopathies as transmissible cerebral amyloidoses. p. 2851-2900. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
63. Gajdusek, D. C., C. J. Gibbs, and M. Alpers. 1966. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209:794-796.
64. Gajdusek, D. C., and V. Zigas. 1957. Degenerative disease of the central nervous system in New Guinea: the endemic occurrence of "kuru" in the native population. N. Engl. J. Med. 257:974-978.
65. Goldfarb, L. G., R. B. Petersen, M. Tabaton, P. Brown, A. C. LeBlanc, P. Montagna, P. Cortelli, J. Julien, C. Vital, W. W. Pendelbury, M. Haltia, P. R. Wills, J. J. Hauw, P. E. McKeever, L. Monari, B. Schrank, G. D. Swergold, L. Autilio-Gambetti, D. C. Gajdusek, E. Lugaresi, and P. Gambetti. 1992. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258:806-808.
66. Gorodinsky, A., and D. A. Harris. 1995. Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J. Cell Biol. 129:619-627.
67. Griffith, J. S. 1967. Self-replication and scrapie. Nature 215:1043-1044.
68. Hadlow, W. J. 1959. Scrapie and kuru. Lancet ii:289-290.
69. Haraguchi, T., S. Fisher, S. Olofsson, T. Endo, D. Groth, A. Tarentino, D. R. Borchelt, D. Teplow, L. Hood, A. Burlingame, E. Lycke, A. Kobata, and S. B. Prusiner. 1989. Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch. Biochem. Biophys. 274:1-13.
70. Harper, J. D., and P. T. Lansbury. 1997. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66:385-407.
71. Harris, D. A., A. Gorodinsky, S. Lehmann, K. Moulder, and S.-L. Shyng. 1996. Cell biology of the prion protein. Curr. Top. Microbiol. Immunol. 207:77-93.
72. Harris, D. A., M. T. Huber, P. van Dijken, S.-L. Shyng, B. T. Chait, and R. Wang. 1993. Processing of a cellular prion protein: identification of N-and C-terminal cleavage sites. Biochemistry 32:1009-1016.
73. Sc-like properties in cultured cells: an experimental model of familial prion diseases, p. 631-643. In K. Iqbal, B. Winblad, T. Nishimura, M. Takeda, and H. M. Wisniewski (ed.), Alzheimer's disease: biology, diagnosis and therapeutics. John Wiley & Sons, Chichester, United Kingdom.
74. Harris, D. A., P. Lele, and W. D. Snider. 1993. Localization of the mRNA for a chicken prion protein by in situ hybridization. Proc. Natl. Acad. Sci. USA 90:4309-4313.
75. Hartl, F. U. 1996. Molecular chaperones in cellular protein folding. Nature 381:571-580.
76. Hay, B., S. B. Prusiner, and V. R. Lingappa. 1987. Evidence for a secretory form of the cellular prion protein. Biochemistry 26:8110-8115.
77. Hegde, R. S., J. A. Mastrianni, M. R. Scott, K. A. Defea, P. Tremblay, M. Torchia, S. J. Dearmond, S. B. Prusiner, and V. R. Lingappa. 1998. A transmembrane form of the prion protein in neurodegenerative disease. Science 279:827-834.
78. Hegde, R. S., S. Voigt, and V. R. Lingappa. 1998. Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. Mol. Cell. 2:85-91.
79. Herms, J. W., H. A. Kretzschmar, S. Titz, and B. U. Keller. 1995. Patchclamp analysis of synaptic transmission to cerebellar Purkinje cells of prion protein knockout mice. Eur. J. Neurosci. 7:2508-2512.
80. Hope, J., L. J. Morton, C. F. Farquhar, G. Multhaup, K. Beyreuther, and R. H. Kimberlin. 1986. The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J. 5:2591-2597.
81. Hornshaw, M. P., J. R. McDermott, and J. M. Candy. 1995. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem. Biophys. Res. Commun. 207:621-629.
82. Horwich, A. L., and J. S. Weissman. 1997. Deadly conformation - protein misfolding in prion disease. Cell 89:499-510.
83. Huang, Z., S. B. Prusiner, and F. E. Cohen. 1996. Structures of prion proteins and conformational models for prion diseases. Curr. Top. Microbiol. Immunol. 207:49-67.
84. Jeffrey, M., C. M. Goodsir, M. E. Bruce, P. A. McBride, J. R. Scott, and W. G. Halliday. 1992. Infection specific prion protein (PrP) accumulates on neuronal plasmalemma in scrapie infected mice. Neurosci. Lett. 147:106-109.
85. Kaneko, K., D. Peretz, K. M. Pan, T. C. Blochberger, H. Wille, R. Gabizon, O. H. Griffith, F. E. Cohen, M. A. Baldwin, and S. B. Prusiner. 1995. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Proc. Natl. Acad. Sci. USA 92:11160-11164.
86. Kaneko, K., M. Vey, M. Scott, S. Pilkuhn, F. E. Cohen, and S. B. Prusiner. 1997. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc. Natl. Acad. Sci. USA 94:2333-2338.
87. Kaneko, K., L. Zulianello, M. Scott, C. M. Cooper, A. C. Wallace, T. L. James, F. E. Cohen, and S. B. Prusiner. 1997. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl. Acad. Sci. USA 94:10069-10074.
88. Kascsak, R. J., R. Rubenstein, P. Merz, R. I. Carp, N. K. Robakis, H. M. Wisniewski, and H. Diringer. 1986. Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J. Virol. 59:676-683.
89. Kocisko, D. A., J. H. Come, S. A. Priola, B. Chesebro, G. J. Raymond, P. T. Lansbury, and B. Caughey. 1994. Cell-free formation of protease-resistant prion protein. Nature 370:471-474.
90. Kocisko, D. A., S. A. Priola, G. J. Raymond, B. Chesebro, P. T. Lansbury, Jr., and B. Caughey. 1995. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc. Natl. Acad. Sci. USA 92:3923-3927.
91. Kretzschmar, H. A., S. B. Prusiner, L. E. Stowring, and S. J. DeArmond. 1986. Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122:1-5.
92. Kristensson, K., B. Feuerstein, A. Taraboulos, W. C. Hyun, S. B. Prusiner, and S. J. DeArmond. 1993. Scrapie prions alter receptor-mediated calcium responses in cultured cells. Neurology 43:2335-2341.
93. Kushnirov, V. V., and M. D. Ter-Avanesyan. 1998. Structure and replication of yeast prions. Cell 94:13-16.
94. Lehmann, S., N. Daude, and D. A. Harris. 1997. A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells. Mol. Brain Res. 52:139-145.
95. Lehmann, S., and D. A. Harris. 1995. A mutant prion protein displays an aberrant membrane association when expressed in cultured cells. J. Biol. Chem. 270:24589-24597.
96. Lehmann, S., and D. A. Harris. 1996. Mutant and infectious prion proteins display common biochemical properties in cultured cells. J. Biol. Chem. 271:1633-1637.
97. Lehmann, S., and D. A. Harris. 1996. Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc. Natl. Acad. Sci. USA 93:5610-5614.
98. Lehmann, S., and D. A. Harris. 1997. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J. Biol. Chem. 272:21479-21487.
99. Lindquist, S. 1997. Mad cows meet Psi-chotic yeast: the expansion of the prion hypothesis. Cell 89:495-498.
100. Lisanti, M. P., P. E. Scherer, J. Vidugiriene, Z. Tang, A. Hermanowski-Vosatka, Y.-H. Tu, R. F. Cook, and M. Sargiacomo. 1994. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J. Cell Biol. 126:111-126.
101. Lledo, P. M., P. Tremblay, S. J. Dearmond, S. B. Prusiner, and R. A. Nicoll. 1996. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc. Natl. Acad. Sci. USA 93:2403-2407.
102. Lopez, C. D., C. S. Yost, S. B. Prusiner, R. M. Myers, and V. R. Lingappa. 1990. Unusual topogenic sequence directs prion protein biogenesis. Science 248:226-229.
103. Low, M. G. 1989. The glycosyl-phosphatidyl anchor of membrane proteins. Biochim. Biophys. Acta 988:427-454.
104. Manson, J., J. D. West, V. Thomson, P. McBride, M. H. Kaufman, and J. Hope. 1992. The prion protein gene: a role in mouse embryogenesis? Development 115:117-122.
105. Manson, J. C., J. Hope, A. R. Clarke, A. Johnston, C. Black, and N. MacLeod. 1995. PrP gene dosage and long term potentiation. Neurodegeneration 4:113-114.
106. McKinley, M. P., R. K. Meyer, L. Kenaga, F. Rahbar, R. Cotter, A. Serban, and S. B. Prusiner. 1991. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J. Virol. 65:1340-1351.
107. McKinley, M. P., A. Taraboulos, L. Kenaga, D. Serban, A. Stieber, S. J. DeArmond, S. B. Prusiner, and N. Gonatas. 1991. Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab. Investig. 65:622-630.
108. Monari, L., S. G. Chen, P. Brown, P. Parchi, R. B. Petersen, J. Mikol, F. Gray, P. Cortelli, P. Montagna, B. Ghetti, L. Goldfarb, D. C. Gajdusek, E. Lugaresi, P. Gambetti, and L. Autilio-Gambetti. 1994. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc. Natl. Acad. Sci. USA 91:2839-2842.
109. Moser, M., R. J. Colello, U. Pott, and B. Oesch. 1995. Developmental expression of the prion protein gene in glial cells. Neuron 14:509-517.
110. Muramoto, T., M. Scott, F. E. Cohen, and S. B. Prusiner. 1996. Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc. Natl. Acad. Sci. USA 93:15457-15462.
111. Narwa, R., and D. A. Harris. Unpublished data.
112. Naslavsky, N., R. Stein, A. Yanai, G. Friedlander, and A. Taraboulos. 1996. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J. Biol. Chem. 272:6324-6331.
113. Nishida, N., S. Katamine, K. Shigematsu, A. Nakatani, N. Sakamoto, S. Hasegawa, R. Nakaoke, R. Atarashi, Y. Kataoka, and T. Miyamoto. 1997. Prion protein is necessary for latent learning and long-term memory retention. Cell. Mol. Neurobiol. 17:537-545.
114. Pan, K.-M., M. Baldwin, J. Nguyen, M. Gasset, A. Serban, D. Groth, I. Mehlhorn, Z. Huang, R. J. Fletterick, F. E. Cohen, and S. B. Prusiner. 1993. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90:10962-10966.
115. Parchi, P., R. Castellani, S. Capellari, B. Ghetti, K. Young, S. G. Chen, M. Farlow, D. W. Dickson, A. A. F. Sima, J. Q. Trojanowski, R. B. Petersen, and P. Gambetti. 1996. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39:767-778.
116. Parchi, P., S. G. Chen, P. Brown, W. Zou, S. Capellari, H. Budka, J. Hainfellner, P. F. Reyes, G. T. Golden, J. J. Hauw, D. C. Gajdusek, and P. Gambetti. 1998. Different patterns of truncated prion protein fragments correlated with distinct phenotypes in P101L Gerstmann-Sträussler-Scheinker disease. Proc. Natl. Acad. Sci. USA 95:8322-8327.
117. Parchi, P., and P. Gambetti. 1995. Human prion diseases. Curr. Opin. Neurol. 8:286-293.
118. Pattison, I. H. 1966. The relative susceptibility of sheep, goats and mice to two types of the goat scrapie agent. Res. Vet. Sci. 7:207-212.
119. Pauly, P. C., and D. A. Harris. 1998. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273:33107-33110.
120. Peretz, D., R. A. Williamson, Y. Matsunaga, H. Serban, C. Pinilla, R. B. Bastidas, R. Rozenshteyn, T. L. James, R. A. Houghten, F. E. Cohen, S. B. Prusiner, and D. R. Burton. 1997. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273:614-622.
121. Petersen, R. B., P. Parchi, S. L. Richardson, C. B. Urig, and P. Gambetti. 1996. Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein J. Biol. Chem. 271:12661-12668.
122. Piccardo, P., B. Ghetti, D. W. Dickson, H. V. Vinters, G. Giaccone, O. Bugiani, F. Tagliavini, K. Young, S. R. Dlouhy, C. Seiler, C. K. Jones, A. Lazzarini, L. I. Golbe, T. R. Zimmerman, S. L. Perlman, D. C. McLachlan, P. H. Stgeorgehyslop, and A. Lennox. 1995. Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165. J. Neuropathol. Exp. Neurol. 54:790-801.
123. Price, D. L., D. R. Borchelt, and S. S. Sisodia. 1993. Alzheimer disease and the prion protein disorders: amyloid β-protein and prion protein amyloidoses. Proc. Natl. Acad. Sci. USA 90:6381-6384.
124. Priola, S. A., and B. Caughey. 1994. Inhibition of scrapie-associated PrP accumulation: probing the role of glycosaminoglycans in amyloidogenesis. Mol. Neurobiol. 8:113-120.
125. Priola, S. A., B. Caughey, R. E. Race, and B. Chesebro. 1994. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J. Virol. 68:4873-4878.
126. Priola, S. A., and B. Chesebro. 1995. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J. Virol. 69:7754-7758.
127. Priola, S. A., and B. Chesebro. 1998. Abnormal properties of prion protein with insertional mutations in different cell types. J. Biol. Chem. 273:11980-11985.
128. Prusiner, S. B. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
129. Prusiner, S. B. 1996. Prions, p. 2901-2950. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
130. Prusiner, S. B. 1997. Prion diseases and the BSE crisis. Science 278:245-251.
131. Prusiner, S. B., and K. K. Hsiao. 1994. Human prion diseases. Ann. Neurol. 35:385-395.
132. Prusiner, S. B., M. Scott, D. Foster, K. M. Pan, D. Groth, C. Mirenda, M. Torchia, S. L. Yang, D. Serban, G. A. Carlson, P. C. Hoppe, D. Westaway, and S. J. DeArmond. 1990. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673-686.
133. Prusiner, S. B., M. R. Scott, S. J. DeArmond, and F. E. Cohen. 1998. Prion protein biology. Cell 93:337-348.
134. Race, R. E., B. Caughey, K. Graham, D. Ernst, and B. Chesebro. 1988. Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J. Virol. 62: 2845-2849.
135. Race, R. E., and D. Ernst. 1992. Detection of proteinase K-resistant prion protein and infectivity in mouse spleen by 2 weeks after scrapie agent inoculation. J. Gen. Virol. 73:3319-3323.
136. Raymond, G. J., J. Hope, D. A. Kocisko, S. A. Priola, L. D. Raymond, A. Bossers, J. Ironside, R. G. Will, S. G. Chen, R. B. Petersen, P. Gambetti, R. Rubenstein, M. A. Smits, P. T. Lansbury, and B. Caughey. 1997. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 388:285-288.
137. Riek, R., S. Hornemann, G. Wider, M. Billeter, R. Glockshuber, and K. Wüthrich. 1996. NMR structure of the mouse prion protein domain PrP(121-231). Nature 382:180-182.
138. Riek, R., S. Hornemann, G. Wider, R. Glockshuber, and K. Wüthrich. 1997. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413:282-288.
139. Rogers, M., A. Taraboulos, M. Scott, D. Groth, and S. B. Prusiner. 1990. Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology 1:101-109.
140. Rogers, M., F. Yehiely, M. Scott, and S. B. Prusiner. 1993. Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc. Natl. Acad. Sci. USA 90:3182-3186.
141. Rubinstein, R., H. Deng, C. L. Scalici, and M. C. Papini. 1991. Alterations in neurotransmitter-related enzyme activity in scrapie-infected PC12 cells. J. Gen. Virol. 72:1279-1285.
142. Safar, J., M. Ceroni, D. C. Gajdusek, and C. J. Gibbs, Jr. 1991. Differences in the membrane interaction of scrapie amyloid precursor proteins in normal and scrapie-or Creutzfeldt-Jakob disease-infected brains. J. Infect. Dis. 163:488-494.
143. Safar, J., P. P. Roller, D. C. Gajdusek, and C. J. Gibbs, Jr. 1993. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 268:20276-20284.
144. Sailer, A., H. Büeler, M. Fischer, A. Aguzzi, and C. Weissmann. 1994. No propagation of prions in mice devoid of PrP. Cell 77:967-968.
145. Sakaguchi, S., S. Katamine, N. Nishida, R. Moriuchi, K. Shigematsu, T. Sugimoto, A. Nakatani, Y. Kataoka, T. Houtani, S. Shirabe, H. Okada, S. Hasegawa, T. Miyamoto, and T. Noda. 1996. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380:528-531.
146. Salès, N., K. Rodolfo, R. Hässig, B. Faucheux, L. Di Giamberardino, and K. L. Moya. 1998. Cellular prion protein localization in rodent and primate brain. Eur. J. Neurosci. 10:2464-2471.
147. Schätzl, H. M., L. Laszlo, D. M. Holtzman, J. Tatzelt, S. J. Dearmond, R. I. Weiner, W. C. Mobley, and S. B. Prusiner. 1997. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J. Virol. 71:8821-8831.
148. Schirmer, E. C., and S. Lindquist. 1997. Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP. Proc. Natl. Acad. Sci. USA 94:13932-13937.
149. Schmid, S. L. 1997. Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu. Rev. Biochem. 66:511-548.
150. Scott, M., D. Foster, C. Mirenda, D. Serban, F. Coufal, M. Wälchli, M. Torchia, D. Groth, G. Carlson, S. J. DeArmond, D. Westaway, and S. B. Prusiner. 1989. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59:847-857.
151. Scott, M., D. Groth, D. Foster, M. Torchia, S. L. Yang, S. J. DeArmond, and S. B. Prusiner. 1993. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73:979-988.
152. Scott, M. R., R. Köhler, D. Foster, and S. B. Prusiner. 1992. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci. 1:986-997.
153. Scott, M. R. D., G. C. Telling, and S. B. Prusiner. 1996. Transgenetics and gene targeting in studies of prion diseases. Curr. Top. Microbiol. Immunol. 207:95-123.
154. Selkoe, D. J. 1996. Cell biology of the β-amyloid precursor protein and the genetics of Alzheimer's disease. Cold Spring Harbor Symp. Quant. Biol. 61:587-596.
155. Shyng, S. L., J. E. Heuser, and D. A. Harris. 1994. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J. Cell Biol. 125:1239-1250.
156. Shyng, S. L., M. T. Huber, and D. A. Harris. 1993. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J. Biol. Chem. 268:15922-15928.
157. Shyng, S. L., K. L. Moulder, A. Lesko, and D. A. Harris. 1995. The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. J. Biol. Chem. 270:14793-14800.
158. C, in cultured cells. J. Biol. Chem. 270:30221-30229.
159. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387:569-572.
160. Singh, N., G. Zanusso, S. G. Chen, H. Fujioka, S. Richardson, P. Gambetti, and R. B. Petersen. 1947. Prion protein aggregation reverted by low tem perature in transfected cells carrying a prion protein gene mutation. J. Biol. Chem. 272:28461-28470.
161. Stahl, N., M. A. Baldwin, A. L. Burlingame, and S. B. Prusiner. 1990 Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 29:8879-8884.
162. Stahl, N., M. A. Baldwin, R. Hecker, K.-M. Pan, A. L. Burlingame, and S. B. Prusiner. 1992. Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 31:5043-5053.
163. Stahl, N., M. A. Baldwin, D. B. Teplow, L. Hood, G. W. Gibson, A. L. Burlingame, and S. B. Prusiner. 1993. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32:1991-2002.
164. Stahl, N., D. R. Borchelt, K. Hsiao, and S. B. Prusiner. 1987. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229-249.
165. Stahl, N., D. R. Borchelt, and S. B. Prusiner. 1990. Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. Biochemistry 29:5405-5412.
166. Stahl, N., D. R. Borchelt, and S. B. Prusiner. 1990. Glycolipid anchors of the cellular and scrapie prion proteins, p. 189-216. In A. J. Turner (ed.), Molecular and cell biology of membrane proteins: glycolipid anchors of cell-surface proteins. Ellis Horwood, London, United Kingdom.
167. Tagliavini, F., F. Prelli, J. Ghiso, O. Bugiani, D. Serban, S. B. Prusiner, M. R. Farlow, B. Ghetti, and B. Frangione. 1991. Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J. 10:513-519.
168. Tagliavini, F., F. Prelli, M. Porro, G. Rossi, G. Giaccone, M. R. Farlow, S. R. Dlouhy, B. Ghetti, O. Bugiani, and B. Frangione. 1994. Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79:695-703.
169. Tagliavini, F., F. Prelli, M. Porro, M. Salmona, O. Bugiani, and B. Frangione. 1992. A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem. Biophys. Res. Commun. 184:1398-1404.
170. Taraboulos, A., A. J. Raeber, D. R. Borchelt, D. Serban, and S. B. Prusiner. 1992. Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell 3:851-863.
171. Taraboulos, A., M. Rogers, D. R. Borchelt, M. P. McKinley, M. Scott, D. Serban, and S. B. Prusiner. 1990. Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc. Natl. Acad. Sci. USA 87:8262-8266.
172. Taraboulos, A., M. Scott, A. Semenov, D. Avrahami, L. Laszlo, S. B. Prusiner, D. Avraham, L. Laszlo, and S. B. Prusiner. 1995. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129: 121-132.
173. Taraboulos, A., D. Serban, and S. B. Prusiner. 1990. Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J. Cell Biol. 110:2117-2132.
174. Tatzelt, J., S. B. Prusiner, and W. J. Welch. 1996. Chemical chaperones interfere with the formation of the scrapie prion protein. EMBO J. 15: 6363-6373.
175. Tatzelt, J., J. Zuo, R. Voellmy, M. Scott, U. Hartl, S. B. Prusiner, and W. J. Welch. 1995. Scrapie prions selectively modify the stress response in neuroblastoma cells. Proc. Natl. Acad. Sci. USA 92:2944-2948.
176. Telling, G. C., M. Scott, J. Mastriani, R. Gabizon, M. Torchia, F. E. Cohen, S. J. DeArmond, and S. B. Prusiner. 1995. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83:79-90.
177. Tobler, I., S. E. Gaus, T. Deboer, P. Achermann, M. Fischer, T. Rulicke, M. Moser, B. Oesch, P. A. McBride, and J. C. Manson. 1996. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380:639-642.
178. Turk, E., D. B. Teplow, L. E. Hood, and S. B. Prusiner. 1988. Purification and properties of the cellular and scrapie hamster prion proteins. Eur. J. Biochem. 176:21-30.
179. Vey, M., S. Pilkuhn, H. Wille, R. Nixon, S. J. Dearmond, E. J. Smart, R. G. W. Anderson, A. Taraboulos, and S. B. Prusiner. 1996. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc. Natl. Acad. Sci. USA 93:14945-14949.
180. Weissmann, C., and A. Aguzzi. 1997. Bovine spongiform encephalopathy and early onset variant Creutzfeldt-Jakob disease. Curr. Opin. Neurobiol 7:695-700.
181. Weissmann, C., A. J. Raeber, D. Shmerling, A. Cozzio, E. Flechsig, and A. Aguzzi. 1999. The use of genetically modified mice in prion research, p. 87-106. In D. A. Harris (ed.), Prions: molecular and cellular biology. Horizon Scientific Press, Wymondham, United Kingdom.
182. Welch, W. J., and P. Gambetti. 1998. Chaperoning brain diseases. Nature 392:23-24.
183. Whittington, M. A., K. C. Sidle, I. Gowland, J. Meads, A. F. Hill, M. S. Palmer, J. G. Jefferys, and J. Collinge. 1995. Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nat. Genet. 9:197-201.
184. Will, R. G., J. W. Ironside, M. Zeidler, S. N. Cousens, K. Estibeiro, A. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, and P. G. Smith. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925.
185. 3 release. Neurology 47:741-750.
186. Yost, C. S., C. D. Lopez, S. B. Prusiner, R. M. Myers, and V. R. Lingappa. 1990. Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 343:669-672.
187. Young, K., P. Piccardo, S. Dlouhy, O. Bugiani, F. Tagliavini, and B. Ghetti. 1999. The human genetic prion diseases, p. 139-175. In D. A. Harris (ed.), Prions: molecular and cellular biology. Horizon Scientific Press, Wymondham, United Kingdom.